Study of LDL557 for knee arthritis in older adults
Part of Bones, joints & muscles, Pain clinical trials.
This trial tests whether a supplement called LDL557 can improve early-stage knee arthritis in people over 65. It aims to reduce pain and slow joint damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 65 or older
- You have mild to moderate knee arthritis (early stage, not severe)
- Your body mass index (BMI) is between 18 and 40
- You are not a smoker
- You do not have diabetes, rheumatoid arthritis, or serious heart or mental health conditions
- You have not had joint surgery, joint injections in the last 6 months, or taken certain arthritis painkillers recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medicine (ALT001) can safely reduce knee pain from osteoarthritis. If you join, you would stop your current pain medicines and take the study drug or a placebo for a set time, while being closely monitored.
This trial tests whether a herbal supplement helps people with osteoarthritis of the knee or hip feel less pain and move better. If you have moderate to severe pain and are able to walk, this study might be a good fit.
This study tests an experimental drug called LY4065967 to see if it can help reduce pain from osteoarthritis in the knee. You'll be in the trial for several months, with regular check-ins and pain assessments.
This trial tests if a Chinese herbal medicine called Tongren-Dahuoluo Bolus can safely reduce knee pain and improve function in people with knee osteoarthritis. It's for those aged 40 to 75 whose X-rays show mild to moderate joint changes and who have had knee pain in the past week.
This trial tests if Antarctic krill oil supplements can reduce knee pain and improve function in people with mild-to-moderate knee osteoarthritis. If you are 45-75 and have knee pain, this study could offer a new natural option.
This Phase 3 study tests diacerein (Artrodar®) to see if it can improve symptoms in people with knee osteoarthritis, and it uses movement and scan-based assessments. It may help reduce walking pain and improve knee function for the right patient group.
Hear when a new Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.